TY - JOUR
T1 - In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange
AU - Johnson, Jennifer L.H.
AU - Dolezal, Melissa C.
AU - Kerschen, Arthur
AU - Matsunaga, Terry O.
AU - Unger, Evan C
PY - 2009/6
Y1 - 2009/6
N2 - The purpose is to prepare 2% w/v emulsions of dodecafluoropentane, perfluorodecalin, and perfluoroctylbromide and compare them for their ability to absorb oxygen. The oxygen uptake capability and volume expansion of each emulsion and the blank vehicle were evaluated in water at 21C and 37C. The average particle size of the dodecafluoropentane emulsion is 400 nm stored at room temperature for 6 months. In comparison to water treated with either the blank vehicle, the perfluorodecalin emulsion, or the perfluoroctylbromide emulsion, the dodecafluoropentane emulsion absorbs 3 times more oxygen at 21C and 7 times more oxygen at 37C. Furthermore, a significantly higher in vitro expansion (5 times) is observed with the dodecafluoropentane emulsion at 37C. As such, DDFP has been hypothesized to be a better oxygen carrier and delivery agent in vivo. This may be applicable to a variety of hypoxic medical conditions where oxygen delivery might be therapeutically beneficial.
AB - The purpose is to prepare 2% w/v emulsions of dodecafluoropentane, perfluorodecalin, and perfluoroctylbromide and compare them for their ability to absorb oxygen. The oxygen uptake capability and volume expansion of each emulsion and the blank vehicle were evaluated in water at 21C and 37C. The average particle size of the dodecafluoropentane emulsion is 400 nm stored at room temperature for 6 months. In comparison to water treated with either the blank vehicle, the perfluorodecalin emulsion, or the perfluoroctylbromide emulsion, the dodecafluoropentane emulsion absorbs 3 times more oxygen at 21C and 7 times more oxygen at 37C. Furthermore, a significantly higher in vitro expansion (5 times) is observed with the dodecafluoropentane emulsion at 37C. As such, DDFP has been hypothesized to be a better oxygen carrier and delivery agent in vivo. This may be applicable to a variety of hypoxic medical conditions where oxygen delivery might be therapeutically beneficial.
UR - http://www.scopus.com/inward/record.url?scp=68849091794&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68849091794&partnerID=8YFLogxK
U2 - 10.1080/10731190903043192
DO - 10.1080/10731190903043192
M3 - Article
C2 - 19548131
AN - SCOPUS:68849091794
SN - 1073-1199
VL - 37
SP - 156
EP - 162
JO - Artificial Cells, Blood Substitutes, and Biotechnology
JF - Artificial Cells, Blood Substitutes, and Biotechnology
IS - 4
ER -